These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 31595270)

  • 1. Immunomodulatory effects of tacrolimus (FK506) for the treatment of allergic diseases.
    Kandikattu HK; Mishra A
    Int J Cell Biol Physiol; 2018; 1(1-2):5-13. PubMed ID: 31595270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of calcineurin in the regulation of human lung mast cell and basophil function by cyclosporine and FK506.
    Harrison CA; Bastan R; Peirce MJ; Munday MR; Peachell PT
    Br J Pharmacol; 2007 Feb; 150(4):509-18. PubMed ID: 17200674
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the efficacy of tacrolimus and cyclosporine A in a murine model of dinitrofluorobenzene-induced atopic dermatitis.
    Yamashita H; Ito T; Kato H; Asai S; Tanaka H; Nagai H; Inagaki N
    Eur J Pharmacol; 2010 Oct; 645(1-3):171-6. PubMed ID: 20674565
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FK506 inhibition of histamine release and cytokine production by mast cells and basophils.
    Sengoku T; Kishi S; Sakuma S; Ohkubo Y; Goto T
    Int J Immunopharmacol; 2000 Mar; 22(3):189-201. PubMed ID: 10685002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tacrolimus hydrate (FK506) ointment on spontaneous dermatitis in NC/Nga mice.
    Hiroi J; Sengoku T; Morita K; Kishi S; Sato S; Ogawa T; Tsudzuki M; Matsuda H; Wada A; Esaki K
    Jpn J Pharmacol; 1998 Feb; 76(2):175-83. PubMed ID: 9541280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cilomilast, tacrolimus and rapamycin modulate dendritic cell function in the elicitation phase of allergic contact dermatitis.
    Bäumer W; Sülzle B; Weigt H; De Vries VC; Hecht M; Tschernig T; Kietzmann M
    Br J Dermatol; 2005 Jul; 153(1):136-44. PubMed ID: 16029339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of topical calcineurin inhibitors in the treatment of childhood atopic dermatitis.
    Breuer K; Werfel T; Kapp A
    Am J Clin Dermatol; 2005; 6(2):65-77. PubMed ID: 15799678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pimecrolimus: a review.
    Gupta AK; Chow M
    J Eur Acad Dermatol Venereol; 2003 Sep; 17(5):493-503. PubMed ID: 12941081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atopic keratoconjunctivitis and atopic dermatitis.
    Guglielmetti S; Dart JK; Calder V
    Curr Opin Allergy Clin Immunol; 2010 Oct; 10(5):478-85. PubMed ID: 20720488
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pimecrolimus Is a Potent Inhibitor of Allergic Reactions to Hymenopteran Venom Extracts and Birch Pollen Allergen In Vitro.
    Heneberg P; Riegerová K; Kučera P
    PLoS One; 2015; 10(11):e0142953. PubMed ID: 26562153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of topical dexamethasone and topical FK506 treatment for the experimental allergic conjunctivitis model in BALB/c mice.
    Shoji J; Sakimoto T; Muromoto K; Inada N; Sawa M; Ra C
    Jpn J Ophthalmol; 2005; 49(3):205-10. PubMed ID: 15944824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical immunomodulators in the management of allergic eye diseases.
    Erdinest N; Solomon A
    Curr Opin Allergy Clin Immunol; 2014 Oct; 14(5):457-63. PubMed ID: 25054831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tacrolimus pharmacology and nonclinical studies: from FK506 to protopic.
    Bekersky I; Lilja H; Lawrence I
    Semin Cutan Med Surg; 2001 Dec; 20(4):226-32. PubMed ID: 11770909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical noncorticosteroid immunomodulation in the treatment of atopic dermatitis.
    Reitamo S; Remitz A; Kyllönen H; Saarikko J
    Am J Clin Dermatol; 2002; 3(6):381-8. PubMed ID: 12113647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dexamethasone and FK506 inhibit expression of distinct subsets of chemokines in human mast cells.
    Kato A; Chustz RT; Ogasawara T; Kulka M; Saito H; Schleimer RP; Matsumoto K
    J Immunol; 2009 Jun; 182(11):7233-43. PubMed ID: 19454720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct evidence that FK506 inhibition of FcepsilonRI-mediated exocytosis from RBL mast cells involves calcineurin.
    Hultsch T; Brand P; Lohmann S; Saloga J; Kincaid RL; Knop J
    Arch Dermatol Res; 1998 May; 290(5):258-63. PubMed ID: 9681677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of topical FK506 (tacrolimus) in a mouse model of allergic rhinitis.
    Shin JH; Park HR; Kim SW; Park CS; Cho JH; Park YJ; Kim SW
    Am J Rhinol Allergy; 2012; 26(2):e71-5. PubMed ID: 22487280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IgG Autoantibodies Against IgE from Atopic Dermatitis Can Induce the Release of Cytokines and Proinflammatory Mediators from Basophils and Mast Cells.
    Poto R; Quinti I; Marone G; Taglialatela M; de Paulis A; Casolaro V; Varricchi G
    Front Immunol; 2022; 13():880412. PubMed ID: 35711458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FK506 and the role of immunophilins in nerve regeneration.
    Gold BG
    Mol Neurobiol; 1997 Dec; 15(3):285-306. PubMed ID: 9457703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel anti-inflammatory drug, SDZ ASM 981, for the treatment of skin diseases: in vitro pharmacology.
    Grassberger M; Baumruker T; Enz A; Hiestand P; Hultsch T; Kalthoff F; Schuler W; Schulz M; Werner FJ; Winiski A; Wolff B; Zenke G
    Br J Dermatol; 1999 Aug; 141(2):264-73. PubMed ID: 10468798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.